DJ Novavax Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 4.63% to $10.30 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.78% to 22,311.98 and Dow Jones Industrial Average falling 1.56% to 46,677.85.
The stock's fall snapped a three-day winning streak.
Novavax Inc. closed 13.95% below its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.39% to $242.04, Pfizer Inc. $(PFE)$ fell 1.61% to $26.86, and Merck & Co. Inc. $(MRK)$ fell 0.26% to $115.91.
Trading volume (3.6 M) remained 1.8 million below its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 12, 2026 17:27 ET (21:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments